Odyssey Health (ODYY) Cash & Equivalents Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -9.44% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 19.87% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -36.69% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 36.60% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 40.99% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 34.11% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.52% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -0.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.25% |
| 10 | Odyssey Health | - | - | - | 158.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 158.23% |
| Oct 31, 2025 | -20.28% |
| Jul 31, 2025 | -35.92% |
| Apr 30, 2025 | -77.13% |
| Jan 31, 2025 | -62.03% |
| Oct 31, 2024 | -51.47% |
| Jul 31, 2024 | -67.99% |
| Apr 30, 2024 | -63.68% |
| Jan 31, 2024 | 38.11% |
| Oct 31, 2023 | -12.24% |
| Jul 31, 2023 | -59.54% |
| Apr 30, 2023 | -64.09% |
| Jan 31, 2023 | 134.97% |
| Oct 31, 2022 | -20.97% |
| Jul 31, 2022 | -24.28% |
| Apr 30, 2022 | 832.89% |
| Jan 31, 2022 | 493.26% |
| Oct 31, 2021 | 676.83% |
| Jul 31, 2021 | 470.81% |
| Apr 30, 2021 | 507.67% |
| Jan 31, 2021 | 438.90% |
| Oct 31, 2020 | 193.93% |
| Jul 31, 2020 | 246.09% |
| Apr 30, 2020 | 122.77% |
| Jan 31, 2020 | -30.00% |
| Oct 31, 2019 | 451.50% |
| Jul 31, 2019 | 324.72% |
| Apr 30, 2019 | -71.99% |
| Jan 31, 2019 | -26.03% |
| Oct 31, 2018 | -44.23% |
| Jul 31, 2018 | -58.23% |
| Apr 30, 2018 | -0.71% |
| Jan 31, 2018 | -77.60% |
| Oct 31, 2017 | -36.92% |
| Jul 31, 2017 | -33.66% |